EpiKidney™ & Incucyte®: Enhanced Renal Toxicity Testing

Authors: Joseph Finelli¹, Paul Keselman², Martha Mayo¹, Nicola Bevan³, Seyoum Ayehunie¹, Alex Armento¹
¹ Mattek, now part of Sartorius, Ashland, MA
² Sartorius Corporate Research, Ann Arbor MI
³ Sartorius Royston, UK

Last Updated: February 2026

Overview

Integrating the EpiKidney™ 3D human model with the Incucyte® Live-Cell Analysis System enhances renal toxicity screening. Traditional methods fall short, prompting the need for predictive human models. EpiKidney™ mimics renal functions for accurate drug-induced nephrotoxicity predictions. The platform enables real-time toxicity monitoring, offering insights into drug effects. The kit includes components for assays, with Cytotox Green for imaging cell death. Demonstrating concentration-dependent nephrotoxin responses, this approach streamlines toxicity quantification and preclinical evaluations, improving drug safety assessments.

 

Resource Details:

  • Document Type: Application Note
  • Page Count: 6
  • Read Time: 8 minutes

 

Key Takeaways

  1. Enhanced Predictive Accuracy: EpiKidney™ 3D model replicates human renal functions, providing accurate predictions of drug-induced nephrotoxicity compared to traditional methods.
  2. Real-Time Monitoring: The Incucyte® System facilitates live-cell analysis, enabling real-time monitoring of renal toxicity and morphological changes in response to drugs.
  3. Comprehensive Assay Kit: The EpiKidney™ kit includes all necessary components for conducting toxicity assays, enhancing the efficiency and ease of preclinical evaluations.
  4. Improved Drug Safety Assessments: This innovative approach aids in understanding renal injury mechanisms, streamlining toxicity quantification, and enhancing overall drug safety assessments.

Request a Quote, Demo, or More Information

What other areas are you interested in? (select all that apply)

Please fill the form to download the App Note